Interventional Glaucoma Business Manager

Job Description

How will you make an impact?
The Interventional Glaucoma Business Manager (iGBM) plays a critical role in driving the adoption and integration of Glaukos technologies within ophthalmic surgical practices. This individual will achieve quarterly sales objectives by engaging targeted ophthalmic surgeons, providing clinical support during procedures, and delivering hands-on training to ensure optimal patient outcomes. The IGBM manages the territory strategically, focusing on customer success, business growth, and long-term partnership development.

What will you do?

Sales Strategy & Execution

• Achieve monthly, quarterly, and annual sales targets across multiple product lines.
• Develop and execute territory business plans to maximize revenue and market penetration.
• Identify and cultivate new business opportunities while maintaining and expanding existing accounts.
• Leverage data and insights to drive adoption and deliver consistent growth.

Clinical Integration & Support

• Conduct surgical wet labs and in-service training to support surgeon onboarding and skill development.
• Attend initial procedures to ensure surgeon proficiency with Glaukos technologies.
• Provide ongoing clinical support and share best practices to improve outcomes and satisfaction.
• Collaborate with surgeons on patient selection and procedural success.

Customer Engagement & Education

• Build strong relationships with key stakeholders at ASCs, hospitals, and private practices.
• Train staff and physicians on patient identification and conversion to Glaukos technologies.
• Serve as a trusted resource for clinical and product education.
• Develop Key Opinion Leaders (KOLs) and product champions to drive peer influence.

Market Development & Events

• Represent Glaukos at targeted industry meetings, conferences, and educational programs.
• Organize local events and peer-to-peer programs to strengthen surgeon engagement.
• Monitor competitive activity and market trends to inform strategy and protect market share.

How will you get here?

• Minimum 5 years of medical sales experience, including at least 3 years in surgical ophthalmology.
• Ophthalmic pharmaceutical experience (4+ years) strongly preferred.
• Proven track record of exceeding sales targets and driving territory growth.
• Experience with new product launches and expanding territories.
• Demonstrated success in building and maintaining strong customer relationships.
• Proficiency in Salesforce CRM and Microsoft Office (PowerPoint, Excel, Word, Outlook).
• Excellent communication, presentation, and organizational skills.
• Strong problem-solving ability and a passion for customer success.
• Must demonstrate professionalism, integrity, and adherence to compliance and administrative standards.

_Total Targeted Compensation $275K plus_

#GKOSUS

_#LI-remote_

We believe great talent deserves great rewards. The base salary range for this position reflects a good-faith estimate of what we reasonably expect to pay for this role at the time of posting. Actual compensation will be based on a variety of factors, including but not limited to the specific role, candidate’s relevant knowledge and experience, education, skills, internal equity, and geographic location. In addition, all full-time employees are eligible to participate in short term incentive opportunities (bonus or commission), RSU grants, Employee Stock Purchase Plan (ESPP) and a comprehensive suite of benefits designed to support health, happiness, and growth—inside and outside of work.

About Us

Founded in 1998, Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases.

Our mission at Glaukos is to truly transform vision by pioneering novel, dropless therapies that can meaningfully advance the standard of care and improve the lives of patients suffering from chronic, sight-threatening eye diseases.

Innovation is at the core of everything we do, and we are resolute in our commitment to challenge conventional thinking with new treatment alternatives that are supported by real science, robust clinical evidence, and an unrelenting focus on patients.

Our constant pursuit of game-changing technologies that disrupt legacy treatment paradigms is encapsulated in the Glaukos mantra “We’ll Go First,” which articulates our willingness to take chances, our determination to forge new ground, and our commitment to continuous improvement in all that we do.

Our company completed an initial public offering in June of 2015, and our shares are traded on the New York Stock Exchange under the ticker symbol “GKOS”. Our global headquarters is in Aliso Viejo, California with additional locations in San Clemente, California, and Burlington, Massachusetts.

Glaukos Corporation is an Equal Opportunity/Affirmative Action Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex including sexual orientation and gender identity, national origin, disability, protected Veteran Status, or any other characteristic protected by applicable federal, state, or local law.

All offers of employment are contingent upon the successful completion of a background check, including successfully passing a drug screen, based on the position and local regulations.